Tom DeLiso

Associate Director, RTSM at Janssen

Speaker

Tom DeLiso is currently an RTSM Associate Director within Clinical Supply Chain at Janssen. In his current role, Tom serves as the RTSM Lead for Immunology, Cardiovascular, Neuroscience and Cross-Pharma Therapeutic Areas. Tom ensures adherence to the IRT Best Practices that have been established for each of these Therapeutic Ares to help maintain consistency across the various clinical trials. Tom has been in the IRT industry for over 20 years. During his career, Tom has worked at an IRT vendor, CRO and sponsor where he has had the opportunity to provide effective IRT solutions on complex trial designs, lead process improvement initiatives and support standards implementation.